Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations andDisclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medplus Health Services' subsidiary Optival Health Solutions has received a 6-day suspension order for the drug license of its Medplus Sai Park Ring Road store in Vijayapura, Karnataka. The order was issued by the Assistant Director, Drugs Control Administration, Bangalore Circle-BIJAPUR on June 30, 2025, under Rule 65 of the Drugs and Cosmetics Act, 1940. The company estimates a potential revenue loss of only around Rs 0.46 lakhs (roughly Rs 46,000) from this single-store action. The filing is being made under SEBI Listing Regulations as a routine disclosure of a regulatory order impacting the subsidiary.
The impact is negligible for shareholders — it affects just one store, lasts only six days, and involves a very small revenue loss. This is unlikely to move the stock price and is essentially a routine regulatory compliance update.